HomeCompareHHSRF vs JNJ

HHSRF vs JNJ: Dividend Comparison 2026

HHSRF yields 500000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HHSRF wins by $4.663521010693878e+33M in total portfolio value
10 years
HHSRF
HHSRF
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full HHSRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HHSRF vs JNJ

📍 HHSRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHHSRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HHSRF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HHSRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HHSRF
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, HHSRF beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HHSRF + JNJ for your $10,000?

HHSRF: 50%JNJ: 50%
100% JNJ50/50100% HHSRF
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HHSRF
No analyst data
Altman Z
-38.4
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HHSRF buys
0
JNJ buys
0
No recent congressional trades found for HHSRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHHSRFJNJ
Forward yield500000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4.663521010693878e+33M$20.0K
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$827.78
Total dividends collected$4.6634009849658873e+33M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HHSRF vs JNJ ($10,000, DRIP)

YearHHSRF PortfolioHHSRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$50,010,700$50,000,000.00$10,676$355.77+$50.00MHHSRF
2$233,748,371,262$233,694,859,813.08$11,407$389.39+$233748.36MHHSRF
3$1,021,074,511,412,696$1,020,824,400,655,446.10$12,198$426.53+$1021074511.40MHHSRF
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$13,056$467.62+$4168597328794.94MHHSRF
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$13,987$513.12+$15905475114600664.00MHHSRF
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$14,998$563.56+$56718938532531060736.00MHHSRF
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$16,098$619.52+$1.8903180743562385e+23MHHSRF
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$17,295$681.69+$5.8879981047651824e+26MHHSRF
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$18,599$750.82+$1.7140642681147225e+30MHHSRF
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.663521010693878e+33MHHSRF

HHSRF vs JNJ: Complete Analysis 2026

HHSRFStock

Hi Ho Silver Resources Inc., a mineral exploration company, explores for and develops mineral properties in Canada. The company holds a 100% interest in the Illite Clay- Kootenay Clay project; and an option to acquire a 100% interest in the Fairview South Okanagan property located in British Columbia. It also has interests in the Isle silver property that consists of 6 units totaling 123.97 hectares located northwest of Kaslo, British Columbia; and Tatler silver property comprising 22 units totaling 452.97 hectares situated to the southwest of Invermere, British Columbia. The company was founded in 2005 and is headquartered in Maple Ridge, Canada.

Full HHSRF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HHSRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HHSRF vs SCHDHHSRF vs JEPIHHSRF vs OHHSRF vs KOHHSRF vs MAINHHSRF vs ABBVHHSRF vs MRKHHSRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.